Matching slides 31,900
Current window 18,091-18,120
Pages 1,064
Rows per page 30
Loop: 27 Cost Of Inactionclear collectionreset all

Loop

18,091-18,120 of 31,900

filter-aware
16
Includes clinical trial abbreviations and source citation in footer.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
The slide appears to be a template or placeholder with only the title present.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide outlines a clinical trial protocol for Itolizumab in patients with active proliferative lupus nephritis (apLN).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
Data includes age, gender, race, country, disease duration, treatment history, LN class, and renal function metrics.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
23
Data cut-off date: September 2, 2022.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a structured table-like layout to categorize safety findings.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
The chart shows concentration over time for different dosage groups (0.4 to 3.2 mg/kg) for Type A and Type B subjects.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
26
The chart uses stacked bars to visualize the breakdown of Complete Response (two categories), Partial Response, and No Response.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
27
The chart tracks subject progress over time (weeks) with markers for treatment milestones and clinical responses.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
28
The chart uses a waterfall-style visualization to show individual subject outcomes relative to a 50% reduction threshold.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
29
The chart includes error bars representing standard error (SE) and sample sizes (n) at each time point.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
30
The table compares interim analysis data for Itolizumab against historical AMP SoC data across 3, 6, and 12-month intervals.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
31
Slide 31 of a presentation deck.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
22
Includes historical data (2012A-2021A) and projections (2022E-2028E).Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
23
The slide uses stacked bar charts to decompose gross profit per metric ton and gross profit as a percentage of net revenue into cost components (Energy, Personnel, Royalties, Production Taxes, Other) and Gross Profit.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
24
Includes historical data (A) and projections (E) from 2018 to 2028.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
25
The slide uses a combination of bar charts for employee counts and cost per ton, and a line chart for the average fully-loaded cost per employee.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
26
Includes historical data (2018-2020) and projections (2021-2028).Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
27
The table includes volume, revenue, freight, cost of goods sold, and EBITDA projections.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
28
The table presents a multi-year financial model for Sisecam Wyoming, including a breakdown of distributable cash flow and distribution splits between SIRE and NRP.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
29
Includes a leverage ratio (Net Debt / Adjusted EBITDA) at the bottom.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
30
The table breaks down consolidated EBITDA, SIRE's share, distributable cash flow, and unit ownership metrics.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
12
Uses large typography for impact; includes source citations for all figures.Foxo | Investor Presentation Deck | 36 slides · FOXO
Pitch deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
The slide uses a three-column layout to segment pain points by stakeholder group.Foxo | Investor Presentation Deck | 36 slides · FOXO
Pitch deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
14
The central graphic represents a timeline or evolution, with 'NOW' at the center.Foxo | Investor Presentation Deck | 36 slides · FOXO
Pitch deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
15
Includes a B2B2C tag and a tech stack/partner ecosystem sidebar.Foxo | Investor Presentation Deck | 36 slides · FOXO
Pitch deck Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
20
Uses a split-screen layout to contrast positive and negative market forces.Hydrafacial | Investor Day Presentation Deck | 149 slides · BeautyHealth
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit